Paragon Biosciences is a biotech company, which focuses on improving people’s lives, form various diseases by innovating medicines for patients and is headed by Jeff Aronin. It hopes to develop biotechnology companies, which will create and avail the medicines to patients worldwide. Paragon serves as an incubator for the development of drugs as well as the financier of biotech startups. The firm aims to help people live longer and happier lives. The company provides medicines, which meet patients’ needs to give longtime healing to healthier living. Paragon strives to understand cause and science behind a particular disease before forming a company to address the condition.

The company utilizes a rational drug development strategy to create a drug, which speeds up approval of medicines. The company hopes to reduce the number of diseases with no treatment available in the market today from more than 6,000 to a lesser numeric. The company collaborates with other healthcare providers to develop new medicines and assist patients’ life better lives. Under the leadership of Jeff Aronin, the company has over 13 FDA drug approvals in last ten years. Paragon develops and finances biotech companies in orders to accelerate scientific breakthroughs. In addition to providing resources, Paragon avails clinical and entrepreneurs to portfolio companies to assist them in gaining exposure, support, guidance and learn better strategy implementation. Paragon Biosciences has its headquarters in Chicago, and some of the portfolio companies include Castle Creek Parma, Harmony Biosciences, Precision BP, and Decade Pharmaceuticals.

Jeffrey Aronin serves as the Chief executive officer and the chair of Paragon Biosciences since the year 2010. He is the founder of Paragon Pharmaceuticals. He is also the founder of MATTER. Jeff is a strategic advisor of Lundbeck since 2009. Aronin has over 20 years of experience in leading pharmaceuticals companies. He also has experience in corporate finance, especially in company acquisitions and mergers. Jeff is an investor, philanthropist, and biotech entrepreneur. Mr. Jeff graduate from the DePaul University where he obtained his M.B.A. He also has Bachelor of Science from the Northern Illinois University. Jeff Aronin and his team at Paragon Biosciences hope to develop new methods to assist patients.